GlassScriptPhysician profile
Boris Petrikovsky
NPI 1801863659
$351.11
in general payments reported to CMS, 2019-2025
10 companies · $90.73 in 2025
The $90.73 reported for 2025 was more than what a typical Maternal & Fetal Medicine provider received nationally (typical 2025 total: $55.21).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.02 · 2021: $69.96 · 2022: $44.52 · 2023: $111 · 2024: $19.27 · 2025: $90.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.34 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120.00 | 2021-2023 | |
| Myriad Women'S Health, INC. | $62.19 | 2023 | Myrisk |
| Takeda Pharmaceuticals U.S.A., INC. | $27.38 | 2025 | Vpriv |
| Shield Therapeutics INC | $24.31 | 2025 | |
| Myovant Sciences INC. | $22.14 | 2022 | |
| Hologic Sales and Service, LLC | $20.76 | 2023 | Aptima |
| Biogen, INC. | $20.03 | 2025 | Zurzuvae |
| Pfizer INC. | $19.27 | 2024 | |
| Millicent US INC | $19.01 | 2025 | Femlyv |
| Amag Pharmaceuticals, INC. | $16.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Petrikovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.